---
category: news
title: "Lantern Pharma Reports Third Quarter 2022 Financial Results and Operational Highlights"
excerpt: "Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR Â® artificial intelligence (\"A.I.\") and machine learning (\"M.L.\") platform to transform the cost,"
publishedDateTime: 2022-11-07T21:18:00Z
originalUrl: "https://technews.tmcnet.com/news/2022/11/07/9707792.htm"
webUrl: "https://technews.tmcnet.com/news/2022/11/07/9707792.htm"
type: article
quality: 0
heat: 0
published: false

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI in Healthcare
  - AI

secured: "AMKtpvo8vQIZVncl/vj0eySGpKkEnxIBnqK0mZSXrMRaIFvK5Xj3I29BcsUkals6oQnzpFAg2hqqBCtEtqopYGmFYuhIYuWOhtPAq3m8Utmy2kRWzRwSvtmXoji3JLnb4PWV48dwXdUfe6dFnX0yLiE7sJI0QNXnbIxy+hTtUXxAj7zxCuPEeKGyvzep5T5CRGqN7Qqecsgar2o/5G0k1T4Pd0aGTGRVQlXZ65AkKyAjglxaDrUsTIEuDE7UD7J3u/W84ioMHRgmavUM9gbDVt0G0gi7L293L3T1J95Pw+B5AILoLEOYaULBD9cz8ACwAj6LnRM1fWKDS2EFvKXeJzJiu0uCbVh1YF+pgBWVzWk=;tvUjKYl7ilqRCN/8VNcTFw=="
---

